Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

STERIS plc (Ireland) Ordinary Shares (NY:STE)

227.57 +1.85 (+0.82%)
Official Closing Price Updated: 4:10 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about STERIS plc (Ireland) Ordinary Shares

< Previous 1 2 3 4 Next >
Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking STERIS (NYSE:STE)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including STERIS... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Zimmer Biomet (NYSE:ZBH) and the best and... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Which S&P500 stocks are gapping on Friday?
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Friday to find the gap up and gap down stocks in today's session. 
Via Chartmill
Forecasting The Future: 4 Analyst Projections For Steris
Via Benzinga
Earnings Scheduled For February 5, 2025
Via Benzinga
Steris Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Earnings Outlook For Steris
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Steris
Via Benzinga
Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
3 Reasons to Sell STE and 1 Stock to Buy Instead
STERIS currently trades at $226.40 per share and has shown little upside over the past six months, posting a small loss of 4.5%. 
Via StockStory
Jim Cramer Says Illumina Is 'Challenged,' Recommends Selling This Industrial Stock
Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and Arista Networks. 
Via Benzinga
BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including BD (NYSE:BDX)... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Where Steris Stands With Analysts
Via Benzinga
Evaluating Steris: Insights From 4 Financial Analysts
Via Benzinga
Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (NYSE:CNMD) and the best and worst... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Solventum (SOLV) Reports Q4: Everything You Need To Know Ahead Of Earnings
Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting results tomorrow afternoon. Here’s what to look for. 
Via StockStory
1 Healthcare Stock Primed for Growth and 2 to Avoid
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and 2024.... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
1 Healthcare Stock Primed for Growth and 2 to Snub
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Why NYSE:STE provides a good dividend, while having solid fundamentals.
Why the dividend investor may take a look at STERIS PLC (NYSE:STE). 
Via Chartmill
What 4 Analyst Ratings Have To Say About Steris
Via Benzinga
STERIS (NYSE:STE) Reports Sales Below Analyst Estimates In Q4 Earnings
Medical equipment and services company Steris (NYSE:STE). fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 5.6% year on year to $1.37 billion. Its non-GAAP profit of $2.32... 
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
What's Going On With Constellation Brands Stock Today?
Constellation Brands' stock rises despite revising FY25 EPS and sales forecasts and anticipating a significant non-cash goodwill impairment. 
Via Benzinga
STE Stock Earnings: Steris Beats EPS, Beats Revenue for Q1 2025
STE stock results show that Steris beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2025. 
Via InvestorPlace
These 10 Large Cap Stocks Shined Brightest Last Week (May 5-May 11, 2024): Are They In Your Portfolio?
Toast, Teva, Vistra, Equinix, Applovin, IFF, Constellation, Emerson, IP, and STERIS were top performers last week. Are they in your portfolio? 
Via Benzinga
Recap: Steris Q3 Earnings
Via Benzinga
Earnings Scheduled For February 7, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million. 
Via Benzinga
Earnings Outlook For Steris
Via Benzinga
STE Stock Earnings: Steris Beats EPS, Misses Revenue for Q4 2024
STE stock results show that Steris beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024. 
Via InvestorPlace
Top Stock Reports For Micron Technology, Anheuser-Busch & Duke Energy
Today's Research Daily features new research reports on 16 major stocks, including Micron Technology, Inc. (MU), Anheuser-Busch InBev SA/NV (BUD), and Duke Energy Corporation (DUK). 
Via Talk Markets
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.